Characteristic
|
Description
|
Symbol
|
Unit
|
Formula
|
Worked example value
|
Dose |
Amount of drug administered. |
|
|
Design parameter
|
500 mmol
|
Dosing interval |
Time between drug dose administrations. |
|
|
Design parameter
|
24 h
|
Cmax |
The peak plasma concentration of a drug after administration. |
|
|
Direct measurement
|
60.9 mmol/L
|
tmax |
Time to reach Cmax. |
|
|
Direct measurement
|
3.9 h
|
Cmin |
The lowest (trough) concentration that a drug reaches before the next dose is administered.
|
|
|
Direct measurement
|
27.7 mmol/L
|
Cavg |
The average plasma concentration of a drug over the dosing interval in steady state.
|
|
|
|
55.0 h×mmol/L
|
Volume of distribution |
The apparent volume in which a drug is distributed (i.e., the parameter relating drug concentration in plasma to drug amount in the body).
|
|
|
|
6.0 L
|
Concentration |
Amount of drug in a given volume of plasma. |
|
|
|
83.3 mmol/L
|
Absorption half-life |
The time required for 50% of a given dose of drug to be absorbed into the systemic circulation.[1]
|
|
|
|
1.0 h
|
Absorption rate constant |
The rate at which a drug enters into the body for oral and other extravascular routes.
|
|
|
|
0.693 h−1
|
Elimination half-life |
The time required for the concentration of the drug to reach half of its original value.
|
|
|
|
12 h
|
Elimination rate constant |
The rate at which a drug is removed from the body. |
|
|
|
0.0578 h−1
|
Infusion rate |
Rate of infusion required to balance elimination. |
|
|
|
50 mmol/h
|
Area under the curve
|
The integral of the concentration-time curve (after a single dose or in steady state).
|
|
|
|
1,320 h×mmol/L
|
|
|
|
Clearance |
The volume of plasma cleared of the drug per unit time. |
|
|
|
0.38 L/h
|
Bioavailability |
The systemically available fraction of a drug. |
|
Unitless |
|
0.8
|
Fluctuation |
Peak–trough fluctuation within one dosing interval at steady state. |
|
|
where
|
41.8%
|